The herpes simplex virus type 1 (HSV-1) (strain 17) DNA polymerase gene has been cloned into an Escherichia coli-yeast shuttle vector fused to the galactokinase gene (GAL-I) promoter. Genes controlled by the GAL-I promoter are induced by galactose, uninduced by raffinose, and repressed by glucose. Cell extracts from a strain of Saccharomyces cerevisiae harboring this vector (Y-MH202, expresser cells) grown in the presence of galactose and assayed in high salt (100 mM ammonium sulfate) contained a novel DNA polymerase activity. No significant high-salt DNA polymerase activity was detected in extracts from expresser cells grown in the presence of raffinose or in extracts from control cells containing the E. coli-yeast shuttle vector without the HSV-1 DNA polymerase gene grown in the presence of raffinose or galactose. Immunoblot analysis of the cell extracts by using a polyclonal rabbit antiserum prepared against a highly purified HSV-1 DNA polymerase preparation revealed the specific induction of the HSV-1 -140-kilodalton DNA polymerase polypeptide in expresser cells grown in galactose. Extracts from the same cells grown in raffinose or control cells grown in either raffinose or galactose did not contain this immunoreactive polypeptide. The high-salt DNA polymerase activity in the extracts from expresser cells grown in galactose was inhibited >90% by either acyclovir triphosphate or aphidicolin, as expected for HSV-1 DNA polymerase. In addition, the high-salt polymerase enzyme activity could be depleted from extracts by immunoprecipitation by using purified immunoglobulin G from this same polyclonal rabbit antiserum. These results demonstrate the successful expression of functional HSV-1 DNA polymerase enzyme in S. cerevisiae.
The herpes simplex virus type 1 (HSV-1) DNA polymerase (pol) has been identified as an approximately 140-kilodalton (kDa) polypeptide which is required for viral DNA replication (5, 6, 26) . The viral enzyme shares specific regions of amino acid sequence homology with other herpesvirus DNA pols and with a variety of eucaryotic DNA pols, including the mammalian and yeast alpha pols in regions believed to correspond to substrate and pyrophosphate binding sites (13, 19, 25, 27, 30) . Despite these similarities to host cell enzymes, HSV pol activity is readily identified because of the ionic strength optimum of the viral enzyme and its much greater sensitivity to agents such as phosphonoacetate and acycloguanosine (acyclovir) triphosphate (ACVTP) (7, 12, 23 ). An improved understanding of the structure of the HSV pol could not only aid in designing new antiviral drugs but could also yield information about the regulation of viral replication, DNA synthesis, and cell proliferation.
While mRNA encoding HSV pol appears to be abundant in the infected cell, only low levels of the pol protein are produced (16, 31) . Several additional polypeptides appear to remain associated with the 140-kDa pol protein through standard purification procedures (26) ; one of these polypeptides is the 65-kDa DNA-binding protein (24) . Therefore, it is difficult to obtain large quantities of homogeneous 140-kDa protein from infected cells for study. Further mechanistic studies on the HSV DNA pol would be greatly facilitated by * Corresponding author. the availability of large quantities of soluble enzyme expressed in a heterologous system such as yeast or bacteria.
Previously, Dorsky et al. (9) successfully expressed a functional form of the HSV pol gene in COS-1 cells from the simian virus 40 early promoter. The low levels of active enzyme expressed in that system were detected by complementation of a temperature-sensitive HSV containing a mutation in pol. Dorsky and Crumpacker (11) have also reported the expression of HSV pol protein in an in vitro translation system. In addition, they reported the expression of high levels of HSV 140-kDa pol protein in Escherichia coli (10) ; however, the expressed protein in E. coli was insoluble and had no readily detectable enzymatic activity.
In this study, the HSV pol gene was expressed in the yeast Saccharomyces cerevisiae. This expression system was chosen for several reasons. First, expression of another HSV enzyme (thymidine kinase) in S. cerevisiae had led to the production of a soluble, functional product (21) Protein analysis. The recombinant cultures were screened for the production of the 140-kDa HSV DNA pol polypeptide by analysis of the enzyme extracts described below on a 10% polyacrylamide gel by the procedure of Heine et al. (14) .
After electrophoresis, the gels were stained by using a commercially available silver stain kit (Bio-Rad Laboratories). Protein determinations were performed by using a Coomassie blue protein assay kit (Bio-Rad).
Preparation of antiserum against HSV-1 DNA pol. HSV-1 DNA pol was purified from HeLa cells infected with strain mP as previously described (26 (25 ,ul) was incubated with 50 RI of distilled water containing 0, 1, or 2 ,ug of purified immunoglobulin G (IgG) for 3 h on ice.
Five microliters of the treated staphylococcus suspension was added, and incubation was continued on ice for 1 h. The mixture was centrifuged at 6,500 rpm in a Microfuge, and the supernatant was assayed for DNA pol activity as described above. The results of assays run either without IgG or without both IgG and Staphylococcus aureus were averaged and used as a control value (100%).
RESULTS
Construction of the expression vector. The construction of the HSV-1 DNA pol expression vector used in this study is shown in Fig. 1 . Plasmid YEp 352 is a high-copy-number, E. coli-yeast shuttle vector used for the expression of genes which contain a functional yeast promoter (15) . YEp 352 contains the 13-lactamase gene for selective growth in ampicillin-containing media in E. coli and the URA-3 gene for selective growth in uracil-deficient media in S. cerevisiae. In addition, the vector contains DNA sequences for autonomous replication in bacteria and in S. cerevisiae. We modified this vector to express foreign genes under the control of a regulatable yeast promoter, the galactokinase promoter (GAL-I). The GAL-I promoter has been described in detail elsewhere (18) and has been used successfully by others to express foreign proteins (18, 29) . The use of a regulatable promoter would enable us to grow cells to high densities before inducing foreign protein expression, thus avoiding potential deleterious effects of foreign protein accumulation on cell growth. Expression of genes controlled by the GAL-I promoter is induced by galactose, repressed by glucose, and uninduced by raffinose (2, 18) .
YEp 352 DNA was digested with restriction endonucleases EcoRI and BamHI to remove part of the multiple cloning site and to generate overhanging 5' ends. An approximately 810-base-pair (bp) fragment containing the GAL-i promoter sequence was isolated from plasmid YCp 125H by digestion with EcoRI and BamHI. The two DNAs were ligated together to form the plasmid pMH 100.
While some investigators (2, 21) have reported successful expression of foreign proteins in S. cerevisiae without the addition of specific transcription termination sequences, others (29) have used these sequences to improve foreign protein expression. To potentially improve the expression of foreign genes, a yeast termination sequence was introduced into the vector. The termination sequence was composed of two synthetic oligonucleotides (Fig. 1) which anneal to form a fragment containing the sequence required for efficient transcription termination from the yeast iso-1-cytochrome c (CYC-I) gene (32) and translation stop codons in the three possible reading frames. The double-stranded oligonucleotide was designed to be directly inserted into the HindIlI restriction site in pMH100. When inserted in the correct orientation, the oligonucleotide would retain the HindIII site only at the end upstream of the three stop codons. The proper orientation of the insert was established by specific differences in the patterns generated by digestion of recombinant plasmids with appropriate restriction enzymes (data not shown). (24) .
The lysates were also analyzed for DNA pol enzyme activity. Each pol which should be present in all lysates. The HSV DNA pol assay conditions were chosen to detect HSV-specific DNA pol activity which is enhanced by high salt (100 mM ammonium sulfate) (23) . In contrast, the yeast alpha DNA pol is inhibited under these salt conditions (3). Table 1 reveals that only Y-MH202, HSV DNA pol expresser cells, grown under inducing conditions (galactose) produce significant amounts of high-salt DNA pol activity. In addition, Table 2 reveals that this novel high-salt activity in the Y-MH202 yeast cell extracts is inhibited by ACVTP and aphidicolin, both potent and well-characterized inhibitors of the HSV DNA pol enzyme (8, 16) . Table 2 also reveals that the low-salt DNA pol activity in all of the extracts tested is sensitive to aphidicolin, which is characteristic of alpha pots (3, 17) and is not sensitive to ACVTP at the concentration tested.
A more complete comparison of the inhibition of ACVTP of HSV pol produced in S. cerevisiae versus HSV pol produced in HeLa cells is shown in Table 3 . These results reveal that the HSV pol enzyme from both sources behaves in a similar fashion; the 50% inhibitory dose is at a concentration of between 1.15 and 2.3 ,uM ACVTP.
To further demonstrate the HSV-specific nature of this high-salt DNA pol activity, we incubated the cell extracts with purified IgG from our rabbit anti-pol serum or with control IgG from a nonimmunized rabbit. Immune complexes were removed with protein A-Staphylococcus aureus by centrifugation, and then residual DNA pol activity from the supernatants was assayed. Two yeast extracts were chosen for comparison; Y-MH101 (galactose-induced) control cell extract was assayed under yeast DNA pol assay conditions to monitor effects of IgG on alpha DNA pol activity, and Y-MH202 (galactose-induced) expresser extract was assayed under HSV DNA pol conditions to monitor effects of the IgG on the high-salt pol activity. Figure 3 reveals that the high-salt activity in galactose-induced Y-MH202 expresser cells can be reduced >50% by immunoprecipitation by using IgG derived from our antiserum to HSV-1 DNA pol, while the alpha pol activity in the galactose-induced Y-MH101 control cell extract is only slightly reduced by reaction with the immune IgG. DNA pol activity in both extracts is only slightly affected by reaction with the control (normal rabbit) IgG.
These results indicate the successful expression of an active form of the HSV-1 DNA pol in S. cerevisiae. 
DISCUSSION
This report details the successful expression of an active eucaryotic DNA pol in a heterologous host. In this study, the HSV pol open reading frame was inserted into a modified yeast expression plasmid such that the HSV DNA pol could be inducibly expressed in yeast cells under the control of the GAL-I promoter. The enzyme expressed in S. cerevisiae possesses the salt resistance and inhibitor sensitivity profiles of the authentic pol enzyme isolated from HSV-1-infected cells. Furthermore, the expressed product possesses HSV-1 pol antigenic determinants as shown by immunoblotting and by immunoprecipitation of pol enzymatic activity from yeast cell extracts.
Expression of the HSV-1 DNA pol enzyme in quantity from a heterologous system will allow further mechanistic studies as well as characterization of complexes between the HSV-1 DNA pol and the other components of the DNA replication machinery of HSV (4 
